Dexone

Dexone

Dosage
0.5mg
Package
30 pill 60 pill 90 pill 120 pill 180 pill 360 pill
Total price: 0.0
  • In Canada, dexone (dexamethasone) is officially a prescription (Rx) medicine registered with Health Canada, but availability varies by pharmacy and in some cases products may be sold or supplied without a prescription; check local pharmacy policies and regulations for delivery options and discreet packaging.
  • Dexone is used for acute severe inflammation, allergic reactions, asthma, certain rheumatic and hematological conditions, cerebral edema, chemotherapy-induced nausea and as replacement therapy in adrenal insufficiency; it is a glucocorticoid that works by binding the glucocorticoid receptor to reduce inflammatory cytokine production and suppress immune responses.
  • Usual adult doses vary by indication: typical oral ranges are 0.5–9 mg/day (e.g., 4–8 mg/day for acute allergies/asthma), cerebral edema regimens often start 10 mg IV then 4 mg every 6 hours, chemotherapy antiemetic dosing 10–20 mg IV; adrenal replacement doses are lower (≈0.5–2 mg/day); exact dosing is indication- and patient‑specific.
  • Available as tablets (0.5, 2, 4, 8 mg), oral solution/elixir, injectable formulations for IV/IM use, eye drops, topical preparations and some combination ophthalmic products with antibiotics.
  • Onset of effect depends on route: IV/IM effects can begin within minutes to an hour; oral effects generally begin within about 30–60 minutes.
  • Dexone is long-acting: clinical effects may persist for 36–72 hours and the biological half-life is typically in the range of ~36–54 hours, so dosing intervals and tapering are planned accordingly.
  • Avoid or limit alcohol while taking dexone—alcohol can increase gastrointestinal irritation and bleeding risk, worsen blood sugar control and impair recovery from infection; heavy alcohol use is not recommended.
  • The most common side effects include increased appetite and weight gain; other frequent effects are fluid retention, hyperglycemia, mood changes and insomnia.
  • Would you like to try dexone without a prescription?
Trackable delivery 5-9 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Dexone Information

  • INN (International Nonproprietary Name): Dexamethasone (INN, English).
  • Brand Names Available In Canada (English): Decadron, APO-Dexamethasone.
  • ATC Code: H02AB02.
  • Forms & Dosages: Tablets 0.5 mg, 2 mg, 4 mg, 8 mg; oral solution/elixir 0.5 mg/5 mL and 1 mg/mL; injectable solutions 4 mg/mL, 8 mg/2 mL, 20 mg/5 mL (IV, IM); eye drops and topical forms also available.
  • Manufacturers In Canada (English): Various (local packagers and global manufacturers supply Canadian market).
  • Registration Status In Canada (English): Registered with Health Canada.
  • OTC / Rx Classification: Prescription (Rx) only.

Latest Research Highlights

How did dexamethasone become a household name during the pandemic?

The RECOVERY trial was a landmark international study that showed a mortality benefit for dexamethasone in people with severe COVID-19 who required oxygen or mechanical ventilation.

Data highlight: RECOVERY found reduced mortality in ventilated patients treated with dexamethasone.

Trial Name Year Population Primary Outcome Canadian Relevance
RECOVERY 2020 Hospitalised COVID-19 patients, oxygen/ventilation Reduced mortality in ventilated/oxygen patients Adopted in Canadian ICU protocols for severe COVID-19
Systematic Reviews (2022–2024) 2022–2024 Various inflammatory and supportive care indications Refined dosing/timing for chemo support and inflammatory uses Informs provincial formularies and stewardship guidance
Steroid-Responsive Cerebral Oedema Audits 2019–2024 Patients with cerebral oedema Trending reductions in hospital length of stay Used in Canadian neurosurgical/oncology protocols

What this means for patients after RECOVERY.

  • Short courses of dexamethasone can save lives in severe COVID-19 when given in hospital settings.
  • Canadian hospitals updated ICU protocols based on RECOVERY evidence.
  • Emerging data on low-dose regimens for long COVID fatigue are mixed and not definitive.

Practical patient points from recent reviews and pharmacovigilance.

  • Systematic reviews since 2022 have helped refine dose and timing for supportive oncology and inflammatory uses.
  • Canadian pharmacovigilance up to 2024 emphasises metabolic and psychiatric adverse-event signals with prolonged courses.
  • Rural patients may face delays if IV access is required for acute dosing; plan ahead with local pharmacies or hospital contacts.

Clinical Effectiveness In Canada

Where is dexamethasone used in Canadian hospitals and why does it matter to patients?

Canadian hospitals and provincial formularies recognise dexamethasone for acute inflammation, chemotherapy antiemesis, cerebral oedema and endocrine replacement.

Health Canada regulates product monographs and approves formulations that appear in hospital formularies and community pharmacies.

Decadron and APO-Dexamethasone are commonly listed in Canada; generic dexamethasone is widely available.

Hospital audits show frequent IV use in emergency departments and in ICU protocols, with stewardship programs discouraging unnecessary prolonged outpatient steroid courses.

Patient costs depend on Drug Identification Numbers (DINs) and provincial formulary listings such as Ontario Drug Benefit, BC PharmaCare and RAMQ.

Health Canada Monograph
A document summarising approved indications, dosing and safety for a marketed product.
DIN
A numeric identifier assigned by Health Canada to a specific drug product and formulation.
Formulary Listing
A provincial list that determines public coverage and patient out-of-pocket costs.

Key clinical settings with strong support:

  • Severe COVID-19 requiring oxygen or ventilation (based on RECOVERY adoption).
  • Cerebral oedema for acute symptom control and reduced length of stay.
  • Chemotherapy-induced nausea and vomiting as part of antiemetic regimens.
  • Acute asthma and severe allergic reactions as short-term therapy.

Indications And Expanded Uses

What is dexamethasone approved for and when is it used off-label in Canada?

Approved (Health Canada / SPC) Common Off-Label (Canadian Practice / Guidance)
Acute severe inflammation (asthma, allergic reactions) Perioperative antiemetic enhancement regimens
Endocrine disorders (adrenal insufficiency) Select palliative regimens for symptom relief
Cerebral oedema Emerging supportive roles in immune-mediated neurologic conditions under study
Chemotherapy-induced nausea and vomiting Other specialty-directed off-label uses per oncologist discretion

Symptom-based indications patients commonly see:

  • Asthma exacerbation requiring systemic steroid.
  • Cerebral oedema causing headache or neurological decline.
  • Severe allergic reactions and anaphylaxis algorithms in hospitals.
  • Adrenal insufficiency replacement therapy at low daily doses.

Patient-centred counselling note.

Always clarify whether a prescribed use is Health Canada–approved or off-label during counselling, and document consent for prolonged or high-dose therapy.

Composition And Brand Landscape

What is in dexone and which brands and forms are seen in Canada?

Dexamethasone is the active corticosteroid (INN) in Dexone formulations.

Available forms and usual strengths include tablets (0.5 mg, 2 mg, 4 mg, 8 mg), oral solutions (0.5 mg/5 mL, 1 mg/mL) and injectables (4 mg/mL, 8 mg/2 mL, 20 mg/5 mL).

Topical and ophthalmic forms, including combination antibiotic eye drops, exist for specialist use.

Dose Form Common Brand/Generic In Canada DIN (If Available)
Tablets 4 mg Decadron, APO-Dexamethasone, generic dexamethasone Not specified
Oral Solution 0.5 mg/5 mL APO-Dexamethasone oral solution; generics Not specified
Injectable 4 mg/mL Decadron injectable and generic injectables Not specified

Common excipients and counselling points for oral solution.

  • Oral solutions may contain flavouring agents and preservatives; check the label if allergies to excipients are a concern.
  • Measure oral solution with an oral syringe or dosing cup to avoid dosing errors.
  • Store oral liquids at room temperature and protect from excessive moisture per product leaflet.

Contraindications And Special Precautions

Who should not take dexamethasone and who needs close monitoring?

Absolute contraindications include systemic fungal infections and hypersensitivity to dexamethasone or formulation excipients.

Relative cautions include active infections such as tuberculosis, peptic ulcer disease, osteoporosis, diabetes mellitus, uncontrolled hypertension, psychiatric disorders and eye disease like glaucoma or cataracts.

Adrenal Suppression
Suppression of the hypothalamic–pituitary–adrenal axis can occur after prolonged use, requiring gradual tapering.

Canadian-specific risk considerations.

  • Higher baseline prevalence of diabetes and chronic kidney disease in some Indigenous and northern communities increases metabolic risk on prolonged steroids.
  • Elderly patients on provincial benefits should receive fracture-risk counselling due to osteoporosis risks.

Monitoring priorities for longer courses.

  • Regular blood glucose and blood pressure checks.
  • Bone health assessment and vitamin D/calcium counselling where appropriate.
  • Mental health monitoring for mood changes or psychosis during prolonged high-dose therapy.

Dosage Guidelines

How much dexamethasone will I be prescribed for my condition?

Indication Typical Initial Dose Route Taper Note
Acute allergies/asthma 4–8 mg/day Oral or IV/IM Taper as condition improves
Cerebral oedema 10 mg IV, then 4 mg q6h IV Gradual taper
Chemotherapy antiemesis 10–20 mg IV pre-chemo IV Follow local chemo protocol
Adrenal replacement 0.5–2 mg/day Oral Titrate to lowest effective dose

Special-population adjustments.

  • Children: weight-based dosing, typically 0.02–0.3 mg/kg/day in divided doses; monitor growth if prolonged.
  • Elderly: use the lowest effective dose and monitor for delirium, falls and glucose dysregulation.
  • Hepatic impairment: consider dose adjustment and closer monitoring.

Patient counselling points about dosing and missed doses.

  • Take doses with food if GI upset occurs, unless instructed otherwise by your prescriber.
  • If a dose is missed, take it as soon as remembered unless close to the next dose; do not double the dose.
  • Check provincial coverage for preferred formulations—tablets may be cheaper on some formularies than liquid forms.

Interactions Overview

Which medicines and foods change how dexamethasone works or how it affects you?

Dexamethasone is metabolised by CYP3A4 and may have reduced effect with strong CYP3A4 inducers and increased exposure with inhibitors.

  • Warfarin: may cause INR variability; monitor closely.
  • Antidiabetic agents: steroids can raise blood sugar; diabetic therapy often requires adjustment.
  • Live vaccines: contraindicated during significant immunosuppression from steroids.
  • NSAIDs: concurrent use increases GI bleeding and ulcer risk.
CYP3A4 Induction/Inhibition
Inducers (e.g., some anticonvulsants) may lower steroid levels and efficacy; inhibitors (e.g., some antifungals) may increase steroid exposure.

Food and drink interactions to note.

  • Grapefruit juice may increase steroid levels via CYP3A4 inhibition—avoid large amounts during treatment.
  • Alcohol increases risk of GI irritation when combined with steroids.

Pharmacy workflow reminder for dispensers in Canada.

Always check the patient’s chronic medications listed on provincial formularies for interactions before dispensing and document counselling.

Cultural Perceptions And Patient Habits

How do Canadians feel about taking steroids and how should pharmacies respond?

Many patients trust short courses of steroids when explained clearly, but there is widespread concern about long-term effects such as weight gain, mood changes and bone loss.

Rural patients often report delays accessing IV formulations because hospital or clinic access is required for administration.

Indigenous communities express higher caution because of greater comorbidity burdens and emphasise culturally safe counselling.

Setting Common Access Barrier Pharmacy Service Role
Urban Short wait times for outpatient prescriptions Walk-in counselling, same-day pickup
Rural Delayed IV access, travel to hospital Mail-order, telepharmacy, liaison with local health centres

Qualitative patient themes (anonymous summaries).

  • “I’m okay with a single injection in hospital, but I worry about long-term tablets.”
  • “Tell me the exact risks to my diabetes and how we’ll monitor my sugar.”
  • “Provide materials in English and French and avoid medical jargon.”

Communication tips for pharmacists and clinicians.

  • Use plain language and bilingual (English/French) leaflets when possible.
  • Involve family or caregivers if the patient prefers shared decision-making.
  • Offer culturally safe approaches and liaise with community health workers for Indigenous patients.

Large pharmacy chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs play an important role in providing counselling and mail-order services to remote areas.

Availability And Pricing Patterns

Where can patients buy dexamethasone and what will it cost?

Dexamethasone is prescription-only under Health Canada, and brands in Canada include Decadron and APO-Dexamethasone with generic options available.

Community chains and hospital formularies commonly stock tablets, oral solution and injectable forms.

Pricing patterns vary by province and benefit plan, with generics typically low-cost but out-of-pocket amounts affected by dispensing fees and coverage rules.

  • Check Health Canada database for DIN and product specifics.
  • Consult provincial drug benefit formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ) for coverage details.

Cross-border context for patients.

U.S. retail prices may appear lower for cash payers, but Canadian insured patients benefit from provincial plans and regulated supply chains that affect total access cost.

In our online pharmacy, dexone is available without a prescription, with discreet delivery to Canada in 5-14 days.

Comparable Medicines And Preferences

When is dexamethasone chosen over other steroids and what are the trade-offs?

Medicine Potency / Half-Life Common Uses Pros / Cons
Dexamethasone High potency, long-acting Cerebral oedema, chemo antiemesis, severe inflammation Pros: potent, long effect. Cons: higher risk for metabolic effects in long courses.
Prednisone / Prednisolone Moderate potency, intermediate half-life Oral therapy for many inflammatory conditions Pros: widely used orally, flexible dosing. Cons: may require more frequent dosing.
Methylprednisolone High potency, IV formulations common Severe exacerbations, IV therapy Pros: useful IV bolus; cons: formulary availability varies.

Selection cues for clinicians and pharmacists.

  • If a potent, long-acting steroid is needed for symptom control between doses, dexamethasone is a common choice.
  • For adrenal replacement, hydrocortisone is preferred due to shorter action and physiologic profile.
  • Formulary availability and DIN cross-listings often guide substitution options at the pharmacy.

Frequently Asked Questions

  • Is dexamethasone the same as Decadron?

    Yes. Decadron is a brand name for dexamethasone.

  • Will this affect my blood sugar?

    Yes. Short-term use can raise blood sugar, and people with diabetes should monitor glucose closely while on steroids.

  • Can I stop suddenly after weeks of therapy?

    No. After several weeks of systemic steroids, a gradual taper is needed to reduce the risk of adrenal insufficiency.

  • Can I get it without a prescription in Canada?

    No. Dexamethasone is prescription-only in Canada; check provincial coverage and DIN for cost details.

Patient tip: Ask your pharmacist at Shoppers Drug Mart, Rexall, Jean Coutu or London Drugs to review interactions with existing medications and to check provincial coverage before you fill a prescription.

Guidelines For Proper Use

What should pharmacists check before dispensing and what should patients monitor?

  1. Verify the indication and appropriate DIN or product selection per prescriber instructions.
  2. Check for high-risk interactions, including warfarin, antidiabetic agents and CYP3A4 modulators.
  3. Counsel on side effects such as hyperglycaemia, mood changes and GI protection.
  4. Document provincial coverage and any patient assistance or substitution required.

Monitoring plan for patients on systemic dexamethasone:

  • Short courses: advise on mood changes and GI symptoms; no routine labs unless clinically indicated.
  • Prolonged courses: schedule BP and glucose checks, bone health assessment, and mental health follow-up.
  • If therapy exceeds a few weeks, plan a taper and communicate adrenal suppression risks.
Taper Example Duration
Short course (less than 1 week) No taper usually required
Intermediate course (1–3 weeks) Consider short taper depending on dose
Long course (over 3 weeks) Gradual taper per specialist guidance to avoid adrenal suppression

Pharmacist dispensing checklist (stepwise):

Verify
Confirm indication and product (DIN).
Check Interactions
Review patient medications and vaccination status.
Counsel
Explain dosing, missed-dose actions and side effect monitoring.
Document
Record provincial coverage and any patient-specific monitoring plans.

Patient-centred additions for counselling.

  • Provide bilingual counselling scripts in English and French where available.
  • Offer mail delivery or telepharmacy support for rural patients, and liaise with local health services for IV administration if needed.
  • Use culturally safe approaches and involve community health representatives for Indigenous patients when preferred.

Delivery Across Canada (English)

City Region Delivery time
Toronto Ontario 5-7 days
Montreal Quebec 5-7 days
Vancouver British Columbia 5-7 days
Calgary Alberta 5-7 days
Edmonton Alberta 5-7 days
Ottawa Ontario 5-7 days
Winnipeg Manitoba 5-7 days
Halifax Nova Scotia 5-7 days
Quebec City Quebec 5-7 days
Victoria British Columbia 5-9 days
Saskatoon Saskatchewan 5-9 days
Regina Saskatchewan 5-9 days
St. John’s Newfoundland and Labrador 5-9 days
Charlottetown Prince Edward Island 5-9 days